NPM1 抗体
(Nucleophosmin (Nucleolar phosphoprotein B23, Numatrin) (NPM1))
This gene encodes a phosphoprotein which moves between the nucleus and the cytoplasm. The gene product is thought to be involved in several processes including regulation of the ARF/p53 pathway. A number of genes are fusion partners have been characterized, in particular the anaplastic lymphoma kinase gene on chromosome 2. Mutations in this gene are associated with acute myeloid leukemia. More than a dozen pseudogenes of this gene have been identified. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Nov 2009].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| NPM1 抗体 (N-Term) | 人 | 小鼠 Monoclonal |
|
|
|
| Recombinant NPM1 抗体 (AA 185-287) | 人 | 小鼠 Monoclonal |
|
|
|
| NPM1 抗体 (AA 185-287) | 人 | 小鼠 Monoclonal |
|
|
|
| Recombinant NPM1 抗体 | 人 | 兔 Monoclonal |
|
|
|
| Recombinant NPM1 抗体 | 人 | 兔 Monoclonal |
|
|
|
| NPM1 抗体 (pThr234) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| NPM1 抗体 (pThr199) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| NPM1 抗体 | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| NPM1 抗体 (AA 100-150) | 人, 小鼠, 大鼠, 兔, Cow, Pig, 犬, 马, 山羊 | 兔 Polyclonal |
|
|
|
| NPM1 抗体 (AA 200-250) | 人, 小鼠, 大鼠, Cow, Pig, 犬, 马 | 兔 Polyclonal |
|
|
|
| NPM1 抗体 (AA 250-294) | 人, 小鼠, 大鼠, 兔, Cow, Pig, 犬, 马 | 兔 Polyclonal |
|
|
|
| NPM1 抗体 (AA 1-209) | 人 | 兔 Polyclonal |
|
|
|
| NPM1 抗体 (AA 20-154) (Biotin) | 小鼠 | 兔 Polyclonal |
|
|
|
| NPM1 抗体 (AA 204-290) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| NPM1 抗体 (AA 204-290) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| NPM1 抗体 (AA 212-292) (FITC) | 小鼠 | 兔 Polyclonal |
|
|
|
| NPM1 抗体 (AA 212-292) (Biotin) | 小鼠 | 兔 Polyclonal |
|
|
|
| NPM1 抗体 (AA 20-154) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| NPM1 抗体 (AA 22-41) | 人, 小鼠, 大鼠, 猴, 兔, Pig, 马, Bat | 兔 Polyclonal |
|
|
|
| NPM1 抗体 (pThr234) | 人, 小鼠, 大鼠, 兔, Cow | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- NA24
- 标记
- unconjugated
- 抗体亚型
- IgG1, kappa
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- rNPM1-1901
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1, kappa
- 抗原表位
- AA 185-287
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- NPM1-3398
- 标记
- unconjugated
- 抗体亚型
- IgG1, kappa
- 抗原表位
- AA 185-287
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- NPM1-7072R
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- NPM1-7072R
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pThr234
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pThr199
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- PLA (Proximity Ligation Assay: 所列应用)
- 适用
- 人, 小鼠, 大鼠, 兔, Cow, Pig, 犬, 马, 山羊
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 100-150
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IP (Immunoprecipitation: 所列应用)
- PLA (Proximity Ligation Assay: 所列应用)
- 适用
- 人, 小鼠, 大鼠, Cow, Pig, 犬, 马
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 200-250
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IP (Immunoprecipitation: 所列应用)
- PLA (Proximity Ligation Assay: 所列应用)
- 适用
- 人, 小鼠, 大鼠, 兔, Cow, Pig, 犬, 马
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 250-294
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-209
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 20-154
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 204-290
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 204-290
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 212-292
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 212-292
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 20-154
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠, 猴, 兔, Pig, 马, Bat
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 22-41
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 小鼠, 大鼠, 兔, Cow
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- pThr234
Latest Publications for our NPM1 抗体
: "Optimized protocol for combined PALM-dSTORM imaging." in: Scientific reports, Vol. 8, Issue 1, pp. 8749, (2018) (PubMed).
: "Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival." in: Theranostics, Vol. 8, Issue 16, pp. 4359-4371, (2018) (PubMed).
: "Effects of hepatitis C virus core protein and nonstructural protein 4B on the Wnt/β-catenin pathway." in: BMC microbiology, Vol. 17, Issue 1, pp. 124, (2017) (PubMed).
: "Retinoic acid and arsenic trioxide trigger degradation of mutated NPM1, resulting in apoptosis of AML cells." in: Blood, Vol. 125, Issue 22, pp. 3447-54, (2015) (PubMed).
: "Non-genotoxic activation of p53 through the RPL11-dependent ribosomal stress pathway." in: Carcinogenesis, Vol. 35, Issue 12, pp. 2822-30, (2014) (PubMed).
: "Toponostics of invasive ductal breast carcinoma: combination of spatial protein expression imaging and quantitative proteome signature analysis." in: International journal of clinical and experimental pathology, Vol. 4, Issue 5, pp. 454-67, (2011) (PubMed).
: "The proteomics of colorectal cancer: identification of a protein signature associated with prognosis." in: PLoS ONE, Vol. 6, Issue 11, pp. e27718, (2011) (PubMed).
: "Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1/K2 transcription factors." in: Journal of virology, Vol. 84, Issue 6, pp. 2719-31, (2010) (PubMed).
: "The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas." in: Cancer genomics & proteomics, Vol. 5, Issue 6, pp. 293-300, (2009) (PubMed).
: "The splicing factor SC35 has an active role in transcriptional elongation." in: Nature structural & molecular biology, Vol. 15, Issue 8, pp. 819-26, (2008) (PubMed).
: "Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival." in: Theranostics, Vol. 8, Issue 16, pp. 4359-4371, (2018) (PubMed).
: "Effects of hepatitis C virus core protein and nonstructural protein 4B on the Wnt/β-catenin pathway." in: BMC microbiology, Vol. 17, Issue 1, pp. 124, (2017) (PubMed).
: "Retinoic acid and arsenic trioxide trigger degradation of mutated NPM1, resulting in apoptosis of AML cells." in: Blood, Vol. 125, Issue 22, pp. 3447-54, (2015) (PubMed).
: "Non-genotoxic activation of p53 through the RPL11-dependent ribosomal stress pathway." in: Carcinogenesis, Vol. 35, Issue 12, pp. 2822-30, (2014) (PubMed).
: "Toponostics of invasive ductal breast carcinoma: combination of spatial protein expression imaging and quantitative proteome signature analysis." in: International journal of clinical and experimental pathology, Vol. 4, Issue 5, pp. 454-67, (2011) (PubMed).
: "The proteomics of colorectal cancer: identification of a protein signature associated with prognosis." in: PLoS ONE, Vol. 6, Issue 11, pp. e27718, (2011) (PubMed).
: "Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1/K2 transcription factors." in: Journal of virology, Vol. 84, Issue 6, pp. 2719-31, (2010) (PubMed).
: "The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas." in: Cancer genomics & proteomics, Vol. 5, Issue 6, pp. 293-300, (2009) (PubMed).
: "The splicing factor SC35 has an active role in transcriptional elongation." in: Nature structural & molecular biology, Vol. 15, Issue 8, pp. 819-26, (2008) (PubMed).
Aliases for NPM1 抗体
nucleophosmin 1 (NPM1) 抗体nucleophosmin 1 (Npm1) 抗体
nucleophosmin (nucleolar phosphoprotein B23, numatrin) L homeolog (npm1.L) 抗体
nucleophosmin 1b (npm1b) 抗体
Nucleophosmin (npm) 抗体
nucleophosmin (NPM1) 抗体
nucleophosmin (nucleolar phosphoprotein B23, numatrin) (NPM1) 抗体
Nucleoplasmin (Nlp) 抗体
nucleophosmin 1a (npm1a) 抗体
B23 抗体
B23NP 抗体
CG7917 抗体
CRP1 抗体
Crp1 抗体
Dmel\\CG7917 抗体
dNLP 抗体
dNLP-S 抗体
NO38 抗体
NPM 抗体
Npm 抗体
npm 抗体
npm1 抗体
npm4 抗体
p22 抗体
sb:cb487 抗体
您还需要查找其他产品吗？
You are here:
